BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+45.36%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$22.7B
AUM Growth
+$22.7B
(+40%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
85.22%
Holding
124
New
14
Increased
20
Reduced
17
Closed
10
Top Buys
Top Sells
Sector Composition
| 1 | Healthcare | 97.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $71.3M | 0.31% |
2,799,577
| – | – |
|
|
ADAP
27
Adaptimmune Therapeutics
ADAP
$13.9M
| $66.8M | 0.29% |
6,675,181
+2,984,874
| +81% | +$29.9M |
|
28
BioCryst Pharmaceuticals
BCRX
$1.74B
| $65.6M | 0.29% |
13,766,405
+2,820,239
| +26% | +$13.4M |
|
|
DBVT
29
DBV Technologies
DBVT
$249M
| $64.2M | 0.28% |
14,614,264
| – | – |
|
30
Zymeworks
ZYME
$1.07B
| $61.6M | 0.27% |
1,708,472
| – | – |
|
31
Rhythm Pharmaceuticals
RYTM
$6.75B
| $60.2M | 0.27% |
2,700,055
-8,145
| -0.3% | -$182K |
|
32
Neurogene
NGNE
$284M
| $56.4M | 0.25% |
3,397,740
| – | – |
|
|
CCXI
33
DELISTED
ChemoCentryx, Inc.
CCXI
| $54.4M | 0.24% |
945,221
+86,206
| +10% | +$4.96M |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| $52.9M | 0.23% |
735,469
| – | – |
|
35
Spyre Therapeutics
SYRE
$1.02B
| $40.5M | 0.18% |
4,379,592
+2,665,988
| +156% | +$24.7M |
|
36
Assembly Biosciences
ASMB
$183M
| $36M | 0.16% |
1,541,618
| – | – |
|
37
Krystal Biotech
KRYS
$4.35B
| $33.9M | 0.15% |
817,631
-128,840
| -14% | -$5.34M |
|
38
Protagonist Therapeutics
PTGX
$3.62B
| $33.8M | 0.15% |
1,911,446
+232,282
| +14% | +$4.1M |
|
39
Merus
MRUS
$5.04B
| $32.8M | 0.14% |
2,037,469
| – | – |
|
40
Apellis Pharmaceuticals
APLS
$3.51B
| $29.3M | 0.13% |
896,551
| – | – |
|
41
Aurinia Pharmaceuticals
AUPH
$1.58B
| $27.7M | 0.12% |
1,701,929
| – | – |
|
42
Alkermes
ALKS
$4.95B
| $24.2M | 0.11% |
1,244,744
| – | – |
|
|
GWPH
43
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $22.7M | 0.1% |
185,045
-185,800
| -50% | -$22.8M |
|
44
Altimmune
ALT
$325M
| $22.6M | 0.1% |
+2,107,600
| New | +$22.6M |
|
45
Adaptive Biotechnologies
ADPT
$1.96B
| $22.4M | 0.1% |
463,539
-280,195
| -38% | -$13.6M |
|
46
Korro Bio
KRRO
$245M
| $22M | 0.1% |
945,719
-234,443
| -20% | -$5.45M |
|
|
TCDA
47
DELISTED
Tricida, Inc. Common Stock
TCDA
| $21.6M | 0.1% |
787,582
-1,878,433
| -70% | -$51.6M |
|
48
Novavax
NVAX
$1.2B
| $20.1M | 0.09% |
+241,376
| New | +$20.1M |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $16.2M | 0.07% |
265,000
+225,000
| +563% | +$13.7M |
|
|
VXRT
50
DELISTED
Vaxart
VXRT
| $14.5M | 0.06% |
+1,639,121
| New | +$14.5M |
|